1. Home
  2. ALLR vs GIFT Comparison

ALLR vs GIFT Comparison

Compare ALLR & GIFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

N/A

Current Price

$0.87

Market Cap

19.3M

Sector

Health Care

ML Signal

N/A

Logo RDE Inc.

GIFT

RDE Inc.

N/A

Current Price

$0.71

Market Cap

22.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
ALLR
GIFT
Founded
2004
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
22.0M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
ALLR
GIFT
Price
$0.87
$0.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
114.8K
★ 474.4K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 52.05
EPS
N/A
★ N/A
Revenue
$320,000.00
★ $83,181,716.00
Revenue This Year
N/A
$6.02
Revenue Next Year
N/A
$8.42
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.77
$0.39
52 Week High
$1.84
$1.29

Technical Indicators

Market Signals
Indicator
ALLR
GIFT
Relative Strength Index (RSI) 39.12 55.30
Support Level $0.79 $0.58
Resistance Level $1.45 $0.76
Average True Range (ATR) 0.07 0.11
MACD 0.01 0.02
Stochastic Oscillator 43.87 80.40

Price Performance

Historical Comparison
ALLR
GIFT

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

About GIFT RDE Inc.

Giftify Inc operates in the incentive and rewards industry with a focus on retail, dining, and entertainment experiences, as the owner and operator of digital platforms, CardCash.com, Restaurant.com, and Takeout7.com. CardCash.com is a secondary gift card exchange platform, allowing consumers and retailers to buy and sell gift cards at various scales from several retailers; Restaurant.com is a restaurant-focused digital deals brand, connecting digital consumers and businesses by offering dining, retail, and entertainment deal options at several restaurants and retailers; and Takeout7 is a restaurant technology company offering online ordering solutions and AI-powered digital marketing services. Giftify has one segment, the sale of gift cards and discount certificates to its customers.

Share on Social Networks: